Gilead PrEP lenacapavir succeeds in Phase 3 trial

The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020.Mike Blake | ReutersGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.None of the roughly 2,000 women in the trial who received Gilead's shot lenacapavir had...

Read more...

First CRISPR gene-editing treatment approved in U.S.

Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin test.Md Babul Hosen | Istock | Getty ImagesThe U.S. Food and Drug Administration on Friday approved the country's first gene-editing treatment, Casgevy, for use in patients with sickle cell disease.The approval comes about...

Read more...

Weight loss drug Wegovy slashes risk of serious heart complications

Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty ImagesNovo Nordisk's Wegovy cut the risk of serious cardiovascular complications in people with obesity and heart...

Read more...

New RSV shots for infants, Abrysvo and Beyfortus, face hurdles in U.S.

A doctor vaccinates an infant against respiratory syncytial virus (RSV) in a treatment room of her paediatric practice.Swen Pförtner | Picture Alliance | Getty ImagesTwo new immunizations promise to protect babies from respiratory syncytial virus – if people can find them. Providers are scrambling to offer Pfizer's vaccine, Abrysvo,...

Read more...